← Eichor
Study identifier: NCT06699095 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Home Rehabilitation As Continuity of Care in MS

Condition: Multiple Sclerosis  ·  Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

RCT pilot study to evaluate adherence, satisfaction and feasibility in the use of a telemedicine station for balance rehabilitation in patients with multiple sclerosis. The platform is designed as a tool for maintenance rehabilitation in a home setting and not as an alternative to intensive treatment in hospital, and is therefore compared to maintenance treatment as usual (TAU) after intensive treatment.

This description comes directly from the study's public registry record.

Talk to the study team

Paolo A Confalonieri, MD  ·  +39 02 2394  ·  paolo.confalonieri@istituto-besta.it

Simone Mercurio, PT  ·  +39 02 2394  ·  simone.mercurio@istituto-besta.it

Always discuss trial participation with your own doctor first.

Locations (3)

IRCCS Istituto Auxologico ItalianoMilan, MI, ItalyRecruiting
Fondazione IRCCS Istituto Neurologico Carlo BestaMilan, MI, ItalyNot Yet Recruiting
IRCCS Santa Maria nascente - Fondazione Don GnocchiMilan, MI, ItalyActive Not Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06699095